$SMMT Was just halted and is now down -36% on the day on news. On Tuesday, I posted this flow in our Discord room of a whale entering highly unusual weekly puts, totalling $300k of premium. I used @unusual_whales to find someone with insider knowledge, epic

#Downgrades - Sep 27, 2024 $AGIO: Leerink Partners Downgrades to Market Perform from Outperform - PT $56 (from $60) $ASC: Fearnley Downgrades to Hold from Buy - PT $19 $BMBL: KeyBanc Downgrades to Sector Weight from Overweight $CLDX: Wolfe Research Downgrades to Peerperform from Outperform $DG: Citi Downgrades to Sell from Neutral - PT $73 (from $91) $HPQ: BofA Securities Downgrades to Neutral from Buy - PT $37 $MEDP: UBS Downgrades to Neutral from Buy - PT $350 (from $420) $SMAR: Citi Downgrades to Neutral from Buy - PT $56.50 (from $63) $SMMT: Citi Downgrades to Neutral from Buy - PT $23 (from $19) $STNG: Fearnley Downgrades to Hold from Buy - PT $80 $TRMD: Fearnley Downgrades to Hold from Buy $VIPS: CCB Int'l Downgrades to Neutral from Outperform - PT $15.50

Bob Duggan 1944年出生，曾就读加州大学圣巴巴拉分校，后来为了躲避被征召去越南战场服兵役，大四时退学又去 UCLA 读了两年书。他很早就开始各种生意的创业，六十岁的时候身价还只有六千五百万美元。他的儿子 26岁的时候不幸因脑癌去世，因此对医药行业产生兴趣。2004年开始累积投入五千万美元购买 Pharmacyclics 股票，此公司 2015年被 AbbVie 收购，Duggan 最初的投入回报七十倍。Duggan 2020年开始担任 Summit Therapeutics ceo, 当时股价只有一点五美元，过去一年涨了超过十倍，现在已经突破二十美元。福布斯估计 Duggan 现在身价大约 160亿美元，换句话说，他的 99.5%的财富是六十岁之后挣的。财富随着本金，经验和网络的积累，有可能越滚越大，达到当初难以想象的高度。他的故事可以参见 Nathan Vardi 的 2023年的书，“For blood and money"